MedTrace Logo

Different Efficacy of IFA Supplementation Among Obese and Non-obese Women

NCT06622551 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2024-10-02

No results posted yet for this study

Summary

This clinical trial aims to learn if there is a relationship between OWT/OB and IDA in nonpregnant women of reproductive age and its impact on iron supplementation. The main questions it aims to answer are:

* Is there any independent association between overweight/obesity and iron deficiency anemia in nonpregnant women after controlling for potential confounding factors?
* Does the effect of iron supplementation on iron status vary between overweight/obese and normal-weight nonpregnant women (as measured by multiple iron biomarkers)? Researchers will compare several biomarkers between the case and control groups after the intervention is given for 90 days.

Participants will:

* Visit the research center before the intervention given and after 90 days
* Take daily iron-folic acid supplements for 90 days
* Keep a diary of their supplement's intake

Conditions

  • Obesity and Overweight
  • Anemia, Iron-Deficiency

Interventions

DIETARY_SUPPLEMENT

Iron-folic acid supplement

The major thing distinguishing this clinical study from another clinical trial is that we differentiate intervention based on nutritional status as we want to observe whether different nutritional status, especially overweight/obese will diminish the effect of IFA supplementation.

Sponsors & Collaborators

  • Universitas Airlangga

    collaborator OTHER

  • Griffith University

    lead OTHER

Principal Investigators

  • Faruk Ahmed, Convenor · Griffith University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
29 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-12-31
Completion
2025-01-30

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06622551 on ClinicalTrials.gov